{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T22:36:45Z","timestamp":1761863805836,"version":"build-2065373602"},"reference-count":36,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,11,13]],"date-time":"2017-11-13T00:00:00Z","timestamp":1510531200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005035","name":"Biotronik","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005035","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004374","name":"Medtronic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004374","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008349","name":"Boehringer Ingelheim","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008349","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004312","name":"Eli Lilly and Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008497","name":"Boston Scientific Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008497","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Cardiovascular Interventions"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.jcin.2017.10.038","type":"journal-article","created":{"date-parts":[[2018,2,14]],"date-time":"2018-02-14T14:10:14Z","timestamp":1518617414000},"page":"448-459","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["\u201cSilent\u201d Diabetes and Clinical Outcome After Treatment With Contemporary Drug-Eluting Stents"],"prefix":"10.1016","volume":"11","author":[{"given":"Clemens","family":"von Birgelen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marlies M.","family":"Kok","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naveed","family":"Sattar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo","family":"Zocca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cees","family":"Doelman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gert D.","family":"Kant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marije M.","family":"L\u00f6wik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liefke C.","family":"van der Heijden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanim","family":"Sen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K. Gert","family":"van Houwelingen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin G.","family":"Stoel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. (Hans) W.","family":"Louwerenburg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc","family":"Hartmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frits H.A.F.","family":"de Man","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerard C.M.","family":"Linssen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carine J.M.","family":"Doggen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenneth","family":"Tandjung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcin.2017.10.038_bib1","doi-asserted-by":"crossref","first-page":"937","DOI":"10.2337\/diabetes.48.5.937","article-title":"Hyperglycemia and cardiovascular disease in type 2 diabetes","volume":"48","author":"Laakso","year":"1999","journal-title":"Diabetes"},{"key":"10.1016\/j.jcin.2017.10.038_bib2","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1161\/01.CIR.0000080897.52664.94","article-title":"Metabolic syndrome with and without C-reactive protein as a predictor as coronary heart disease and diabetes in the West of Scotland coronary prevention study","volume":"108","author":"Sattar","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.jcin.2017.10.038_bib3","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1056\/NEJMoa1211585","article-title":"Strategies for multivessel revascularization in patients with diabetes","volume":"367","author":"Farkouh","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jcin.2017.10.038_bib4","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1016\/j.jacc.2014.01.064","article-title":"Impact of coronary lesion complexity on drug-eluting stent outcomes in patients with and without diabetes mellitus: analysis from 18 pooled randomized trials","volume":"63","author":"Kedhi","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jcin.2017.10.038_bib5","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1161\/CIRCULATIONAHA.105.562421","article-title":"Randomized comparison of sirolimus-eluting stent versus standard stent for percutaneous coronary revascularization in diabetic patients: the diabetes and sirolimus-eluting (DIABETES) trial","volume":"112","author":"Sabate","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.jcin.2017.10.038_bib6","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.e5170","article-title":"Outcomes with various drug eluting or bare metal stents in patients with diabetes mellitus: mixed treatment comparison analysis of 22,844 patient years of follow-up from randomised trials","volume":"345","author":"Bangalore","year":"2012","journal-title":"BMJ"},{"key":"10.1016\/j.jcin.2017.10.038_bib7","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1161\/CIRCULATIONAHA.113.002114","article-title":"Coronary artery revascularization in patients with diabetes mellitus","volume":"128","author":"Armstrong","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.jcin.2017.10.038_bib8","doi-asserted-by":"crossref","first-page":"3035","DOI":"10.1093\/eurheartj\/eht108","volume":"34","author":"Ryden","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jcin.2017.10.038_bib9","first-page":"S81","article-title":"Diagnosis and classification of diabetes mellitus","volume":"27","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jcin.2017.10.038_bib10","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.jacc.2011.08.080","article-title":"Prediabetes, Metabolic syndrome and cardiovascular risk","volume":"59","author":"Grundy","year":"2012","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jcin.2017.10.038_bib11","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1007\/s00125-009-1651-x","article-title":"Glycaemic status influences the nature and severity of coronary artery disease","volume":"53","author":"Berry","year":"2010","journal-title":"Diabetologia"},{"key":"10.1016\/j.jcin.2017.10.038_bib12","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1001\/jamacardio.2016.5190","article-title":"Five-year outcome after implantation of zotarolimus- and everolimus-eluting stents in randomized trial participants and nonenrolled eligible patients: a secondary analysis of a randomized clinical trial","volume":"2","author":"von Birgelen","year":"2017","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jcin.2017.10.038_bib13","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1016\/j.amjcard.2012.07.019","article-title":"Comparison of frequency of periprocedural myocardial infarction in patients with and without diabetes mellitus to those with previously unknown but elevated glycated hemoglobin levels (from the TWENTE trial)","volume":"110","author":"Tandjung","year":"2012","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jcin.2017.10.038_bib14","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1093\/eurheartj\/ehv008","article-title":"Screening for dysglycaemia in patients with coronary artery disease as reflected by fasting glucose, oral glucose tolerance test, and HbA1c: a report from EUROASPIRE IV\u2013a survey from the European Society of Cardiology","volume":"36","author":"Gyberg","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jcin.2017.10.038_bib15","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/S2213-8587(16)00085-1","article-title":"Screening for diabetes in patients with cardiovascular disease: HbA1c trumps oral glucose tolerance testing","volume":"4","author":"Sattar","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.jcin.2017.10.038_bib16","doi-asserted-by":"crossref","first-page":"2923","DOI":"10.1007\/s00125-011-2253-y","article-title":"Oral glucose tolerance and HbA1c for diagnosis of diabetes in patients undergoing coronary angiography: the Silent Diabetes Study","volume":"54","author":"Doerr","year":"2011","journal-title":"Diabetologia"},{"key":"10.1016\/j.jcin.2017.10.038_bib17","doi-asserted-by":"crossref","first-page":"2607","DOI":"10.1016\/S0140-6736(16)31920-1","article-title":"Very thin strut biodegradable polymer everolimus-eluting and sirolimus-eluting stents versus durable polymer zotarolimus-eluting stents in allcomers with coronary artery disease (BIO-RESORT): a three-arm, randomised, non-inferiority trial","volume":"388","author":"von Birgelen","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.jcin.2017.10.038_bib18","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1373\/clinchem.2010.161596","article-title":"Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus","volume":"57","author":"Sacks","year":"2011","journal-title":"Clin Chem"},{"key":"10.1016\/j.jcin.2017.10.038_bib19","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.e4624","article-title":"Risk identification and interventions to prevent type 2 diabetes in adults at high risk: summary of NICE guidance","volume":"345","author":"Chatterton","year":"2012","journal-title":"BMJ"},{"key":"10.1016\/j.jcin.2017.10.038_bib20","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.2337\/dc09-9033","article-title":"International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes","volume":"32","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jcin.2017.10.038_bib21","doi-asserted-by":"crossref","first-page":"871","DOI":"10.4244\/EIJV5I7A146","article-title":"Myocardial infarction adjudication in contemporary all-comer stent trials: balancing sensitivity and specificity. Addendum to the historical MI definitions used in stent studies","volume":"5","author":"Vranckx","year":"2010","journal-title":"EuroIntervention"},{"key":"10.1016\/j.jcin.2017.10.038_bib22","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.diabres.2013.11.002","article-title":"Global estimates of diabetes prevalence for 2013 and projections for 2035","volume":"103","author":"Guariguata","year":"2014","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.jcin.2017.10.038_bib23","doi-asserted-by":"crossref","first-page":"2596","DOI":"10.1007\/s00125-014-3378-6","article-title":"3-year follow-up of the Silent Diabetes Study","volume":"57","author":"Schnell","year":"2014","journal-title":"Diabetologia"},{"key":"10.1016\/j.jcin.2017.10.038_bib24","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ejim.2016.09.007","article-title":"Prospective study of the impact of diabetes mellitus newly diagnosed by glycated hemoglobin on outcomes in patients undergoing percutaneous coronary intervention","volume":"37","author":"Tailakh","year":"2017","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.jcin.2017.10.038_bib25","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.amjcard.2015.11.060","article-title":"Utility of glycated hemoglobin for assessment of glucose metabolism in patients with ST-segment elevation myocardial infarction","volume":"117","author":"Aggarwal","year":"2016","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jcin.2017.10.038_bib26","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1016\/j.amjcard.2003.08.008","article-title":"Relation of hemoglobin A1c to rate of major adverse cardiac events in nondiabetic patients undergoing percutaneous coronary revascularization","volume":"92","author":"Corpus","year":"2003","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jcin.2017.10.038_bib27","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.amjcard.2005.03.076","article-title":"Frequency of undiagnosed diabetes mellitus in patients with acute coronary syndrome","volume":"96","author":"Conaway","year":"2005","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jcin.2017.10.038_bib28","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0002-8703(03)00235-7","article-title":"Effect of fasting glucose levels on mortality rate in patients with and without diabetes mellitus and coronary artery disease undergoing percutaneous coronary intervention","volume":"146","author":"Muhlestein","year":"2003","journal-title":"Am Heart J"},{"key":"10.1016\/j.jcin.2017.10.038_bib29","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1161\/CIRCULATIONAHA.110.985911","article-title":"Prognostic value of admission glycosylated hemoglobin\u00a0and glucose in nondiabetic patients with ST-segment-elevation myocardial infarction treated with percutaneous coronary intervention","volume":"124","author":"Timmer","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.jcin.2017.10.038_bib30","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1016\/j.jacc.2009.10.060","article-title":"Pre-diabetes and the risk for cardiovascular disease: a systematic review of the evidence","volume":"55","author":"Ford","year":"2010","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jcin.2017.10.038_bib31","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.jcin.2016.12.003","article-title":"Incidence, patterns, and associations between dual-antiplatelet therapy cessation and risk for adverse events among patients with and without diabetes mellitus receiving drug-eluting stents: results from the PARIS registry","volume":"10","author":"Faggioni","year":"2017","journal-title":"J Am Coll Cardiol Intv"},{"key":"10.1016\/j.jcin.2017.10.038_bib32","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1016\/j.jacc.2007.05.049","article-title":"Impact of platelet reactivity on cardiovascular outcomes in patients with type 2 diabetes mellitus and coronary artery disease","volume":"50","author":"Angiolillo","year":"2007","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jcin.2017.10.038_bib33","doi-asserted-by":"crossref","first-page":"372","DOI":"10.2337\/dc06-1625","article-title":"Platelet response to clopidogrel is attenuated in diabetic patients undergoing coronary stent\u00a0implantation","volume":"30","author":"Geisler","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jcin.2017.10.038_bib34","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.amjmed.2010.11.025","article-title":"Implications of using hemoglobin A1C for diagnosing diabetes mellitus","volume":"124","author":"Malkani","year":"2011","journal-title":"Am J Med"},{"key":"10.1016\/j.jcin.2017.10.038_bib35","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.ahj.2014.06.023","article-title":"Prevalence of glucose abnormalities among patients presenting with an acute myocardial infarction","volume":"168","author":"Arnold","year":"2014","journal-title":"Am Heart J"},{"key":"10.1016\/j.jcin.2017.10.038_bib36","doi-asserted-by":"crossref","first-page":"2646","DOI":"10.1016\/j.jacc.2017.04.014","article-title":"Novel diabetes drugs and the cardiovascular specialist","volume":"69","author":"Sattar","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"}],"container-title":["JACC: Cardiovascular Interventions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936879817322136?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936879817322136?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T18:07:08Z","timestamp":1761847628000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1936879817322136"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":36,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["S1936879817322136"],"URL":"https:\/\/doi.org\/10.1016\/j.jcin.2017.10.038","relation":{},"ISSN":["1936-8798"],"issn-type":[{"type":"print","value":"1936-8798"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"\u201cSilent\u201d Diabetes and Clinical Outcome After Treatment With Contemporary Drug-Eluting Stents","name":"articletitle","label":"Article Title"},{"value":"JACC: Cardiovascular Interventions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcin.2017.10.038","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation.","name":"copyright","label":"Copyright"}]}}